23. Newman H and Gooding C. Viral ocular manifestations: a broad overview. Rev Med Virol 2013; 23: 281-94.
24. Miller CS, Berger JR, Mootoor Y, et al. High prevalence of multiple human herpesviruses in saliva from human immunodeficiency virus-infected persons in the era of highly active antiretroviral therapy. J Clin Microbiol 2006; 44: 2409-15.
25. Pellett PE and Roizman B. The Family of Herpesviridae: A brief introduction. In: Knipe DM, Howley PM, Griffin DE, et al., eds. Fields Virology. 5th ed. Vol. 2. Philadelphia: Lippincott-Williams and Wilkins, 2007: 2479-99.
26. Chakraborty N, Bhattacharyya S, De C, et al. Incidence of multiple Herpesvirus infection in HIV seropositive patients, a big concern for Eastern Indian scenario. Virol J 2010; 7: 147-53.
27. Jansen K, Haastert B, Michalik C, et al. Incidence and risk factors of herpes zoster among hiv-positive patients in the german competence network for HIV/AIDS (KompNet): a cohort study analysis. BMC
Infect Dis 2013; 13: 372-81.
28. Liesegang TJ. Herpes simplex virus epidemiology and ocular importance. Cornea 2001; 20: 1-13. 29. Freeman WR, Lerner CW, Mines JA, et al. A prospective study of the ophthalmologic findings in the
acquired immune deficiency syndrome. Am J Ophthalmol 1984; 97: 133-42.
30. Doan S, Cochereau I, Guvenisik N, et al. Cytomegalovirus retinitis in HIV-infected patients with and without highly active antiretroviral therapy. Am J Ophthalmol 1999; 128: 250-1.
31. Otiti-Sengeri J, Meenken C, van den Horn GJ, et al. Ocular immune reconstitution inflammatory syndromes. Curr Opin HIV AIDS 2008; 3: 432-7.
32. Robinson MR, Reed G, Csaky KG, et al. Immune-recovery uveitis in patients with cytomegalovirus retinitis taking highly active antiretroviral therapy. Am J Ophthalmol 2000; 130: 49-56.
33. Joint United Nations Programme on HIV/AIDS (UNAIDS). Fact sheet 2015. Geneva: UNAIDS; 2015. 34. Schaftenaar E, Verjans GM, Getu S, et al. High seroprevalence of human herpesviruses in HIV-
infected individuals attending primary healthcare facilities in rural South Africa. PLoS One 2014; 9: e99243.
35. Leichliter JS, Lewis DA, Sternberg M, et al. Health care seeking among men with genital ulcer dis- ease in South Africa: correlates and relationship to human immunodeficiency virus-1 and herpes simplex virus type 2 detection and shedding. Sex Transm Dis 2011; 38: 865-70.
36. Otwombe KN, Variava E, Holmes CB, et al. Predictors of delay in the diagnosis and treatment of suspected tuberculosis in HIV co-infected patients in South Africa. Int J Tuberc Lung Dis 2013; 17: 1199-205.
37. Kong VY, Van der Linde S, Aldous C, et al. Quantifying the disparity in outcome between urban and rural patients with acute appendicitis in South Africa. S Afr Med J 2013; 103: 742-5.
38. Richards JC, Maartens G and Davidse AJ. Course and complications of varicella zoster ophthalmicus in a high HIV seroprevalence population (Cape Town, South Africa). Eye (Lond) 2009; 23: 376-81. 39. Patel P, Bush T, Mayer KH, et al. Prevalence and risk factors associated with herpes simplex virus-2
infection in a contemporary cohort of HIV-infected persons in the United States. Sex Transm Dis 2012; 39: 154-60.
40. Munawwar A and Singh S. Human Herpesviruses as Copathogens of HIV Infection, Their Role in HIV Transmission, and Disease Progression. J Lab Physicians 2016; 8: 5-18.
41. Des Jarlais DC, Arasteh K, McKnight C, et al. HSV-2 co-infection as a driver of HIV transmission among heterosexual non-injecting drug users in New York City. PLoS One 2014; 9: e87993. 42. Cohen MS and Gay CL. Treatment to prevent transmission of HIV-1. Clin Infect Dis 2010; 50: S85-95. 43. Upadhyay MP, Srinivasan M and Whitcher JP. Microbial keratitis in the developing world: does
Chapter 8
136
44. Keay L, Edwards K, Naduvilath T, et al. Microbial keratitis predisposing factors and morbidity. Oph-
thalmology 2006; 113: 109-16.
45. Hodge WG, Seiff SR and Margolis TP. Ocular opportunistic infection incidences among patients who are HIV positive compared to patients who are HIV negative. Ophthalmology 1998; 105: 895-900. 46. Schaftenaar E, Peters RPH, Baarsma GS, et al. Clinical and corneal microbial profile of infectious
keratitis in a high HIV prevalence setting in rural South Africa. Accepted for publication. Eur J Clin
Microbiol Infect Dis 2016.
47. Yorston D and Foster A. Herpetic keratitis in Tanzania: association with malaria. Br J Ophthalmol 1992; 76: 582-5.
48. Ashaye A and Aimola A. Keratitis in children as seen in a tertiary hospital in Africa. J Natl Med Assoc 2008; 100: 386-90.
49. Vafai A and Berger M. Zoster in patients infected with HIV: a review. Am J Med Sci 2001; 321: 372-80. 50. Liesegang TJ. Herpes zoster virus infection. Curr Opin Ophthalmol 2004; 15: 531-6.
51. Veenstra J, Krol A, Van Pragg RM, et al. Herpes zoster immunological deterioration and disease progression in HIV-1 infection. AIDS 1995; 9: 1153-8.
52. Hodge WG and Margolis TP. Herpes simplex virus keratitis among patients who are positive or negative for human immunodeficiency virus: an epidemiologic study. Ophthalmology 1997; 104: 120-4.
53. Sharma S. Diagnosis of infectious diseases of the eye. Eye 2012; 26: 177-84.
54. Boisjoly HM, Pavan-Langston D, Kenyon KR, et al. Superinfections in herpes simplex keratitis. Am J
Ophthalmol 1983; 96: 354-61.
55. Poole TR, Hunter DL, Maliwa EM, et al. Aetiology of microbial keratitis in northern Tanzania. Br J
Ophthalmol 2002; 86: 941-2.
56. Thomas PA and Geraldine P. Infectious keratitis. Curr Opin Infect Dis 2007; 20: 129-41
57. Burton MJ, Pithuwa J, Okello E, et al. Microbial keratitis in East Africa: why are the outcomes so poor? Ophthalmic Epidemiol 2011; 18: 158-63.
58. Kaufman SC. Anterior segment complications of herpes zoster ophthalmicus. Ophthalmology 2008;
115: S24-32.
59. Marsh RJ and Cooper M. Ophthalmic herpes zoster. Eye (Lond) 1993; 7: 350-70.
60. Bayu S and Alemayehu W. Clinical profile of herpes zoster ophthalmicus in Ethiopians. Clin Infect Dis 1997; 24: 1256-60.
61. Buchbinder SP, Katz MH, Hessol NA, et al. Herpes zoster and human immunodeficiency virus infec- tion. J Infect Dis 1992; 166: 1153-6.
62. Schaftenaar E, Meenken C, Baarsma GS et al. Early- and late-stage ocular complications of herpes zoster ophthalmicus in rural South Africa. Trop Med Int Health 2016; 21: 334-9.
63. Nithyanandam S, Joseph M and Stephen J. Ocular complications and loss of vision due to herpes zoster ophthalmicus in patients with HIV infection and a comparison with HIV-negative patients.
Int J STD AIDS 2013; 24: 106-9.
64. Ritterband DC and Friedberg DN. Virus infections of the eye. Rev Med Virol 1998; 8: 187-201. 65. Nasoodi A, Lim LT, Al-Ani A, et al. What you can see in your patient’s eyes? Review of ocular mani-
festations of HIV in HAART era. Int J STD AIDS 2008; 19: 4-11.
66. London NJ, Rathinam SR and Cunningham ET Jr. The epidemiology of uveitis in developing coun- tries. Int Ophthalmol Clin 2010; 50: 1-17.
67. Jabs DA, Nussenblatt RB and Rosenbaum JT; Standardization of Uveitis Nomenclature (SUN) Work- ing Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 2005; 140: 509-16.
137